Analysis of 2020 statistics on cannabis edibles shows that the edibles market has skyrocketed in the United States. The increase in market demand likely associated with the fact that households are confined 24/7, out of this situation has arisen the need for relatively subtle edibles. DEBORAH AGBOOLA – cannabis tech. March 05, 2021
Annual data from Seattle-based cannabis analytics company Headset shows sales of adult and medical edibles are up 60% in seven state markets. Growing from $767 million in 2019 to $1.23 billion in 2020, the edibles sector has overtaken the total cannabis market, which grew by 54% in 2019.
Marijuana use is still illegal at the federal level in the United States, and with more favorable legislation (both for medicinal and recreational use) and ongoing reforms, we are on the brink of a new era. Market growth is driving innovation and not just in the production of cannabis edibles, but also in their testing and measurement.
The growing demand for cannabis-based food and drug development has presented a number of challenges for the FDA and related manufacturing industries, most notably the rapid technologization of manufacturing processes, which not only increase production efficiency, but also help to meet to standards. regulatory challenges as authorities take control of a newly legalized industry.
The water-insoluble property of CBD extracts poses a significant problem, as many beverage companies such as Coca-Cola would love to create CBD-infused drinks unless a technology like nanotechnology comes into play.
According to Research and Markets, the global nanotechnology market could reach $125 billion by 2024. A percentage of this astronomical number is due to the application of nanotechnology in the cannabis industry. Innovation, which consists of creating and using elements with unique properties and functions due to their small size, paved the way for advances in the processing of cannabis edibles using nanoemulsions.
Through nanoencapsulation technology, nanoemulsions, which transform substances insoluble in water, such as cannabinoids, into nanometric particles, also provide greater efficiency to consumers through greater bioavailability.
The FDA recognizes the potential opportunities that cannabis and cannabis-derived compounds may offer and has recognized its significant interest in these possibilities. The various state regulations pose a magnanimous barrier to the manufacturing industries and their (niche) customer base will also appreciate this because, through better internal testing and quality control programs, more products can be manufactured with less inputs, maximizing productivity. productivity. safety, quality, productivity and profits.
According to Kim Rael, president and CEO of Azuca, efficiency means meeting the needs of target consumers, who want to enjoy their edibles socially and feel the effect in real time, rather than waiting until it starts.
With this understanding, Azuca developed TiME (Thermodynamic Individual Molecular Encapsulation), a technology that tricks the body into processing cannabis molecules more quickly. This technology causes molecules to bypass the liver and move straight into the bloodstream, reducing reaction time.
Here’s more: Brownie com manteiga de cannabis, Legalização da cannabis e redução do uso de opioides por pacientes com câncer e dores, Brasileira conta como é trabalhar com cannabis no Canadá, Faire germer des graines de cannabis, 3 plantas comestíveis que quase toda calçada tem 1.2